Literature DB >> 9081618

Erythropoietin gene expression in human, monkey and murine brain.

H H Marti1, R H Wenger, L A Rivas, U Straumann, M Digicaylioglu, V Henn, Y Yonekawa, C Bauer, M Gassmann.   

Abstract

The haematopoietic growth factor erythropoietin is the primary regulator of mammalian erythropoiesis and is produced by the kidney and the liver in an oxygen-dependent manner. We and others have recently demonstrated erythropoietin gene expression in the rodent brain. In this work, we show that cerebral erythropoietin gene expression is not restricted to rodents but occurs also in the primate brain. Erythropoietin mRNA was detected in biopsies from the human hippocampus, amygdala and temporal cortex and in various brain areas of the monkey Macaca mulatta. Exposure to a low level of oxygen led to elevated erythropoietin mRNA levels in the monkey brain, as did anaemia in the mouse brain. In addition, erythropoietin receptor mRNA was detected in all brain biopsies tested from man, monkey and mouse. Analysis of primary cerebral cells isolated from newborn mice revealed that astrocytes, but not microglia cells, expressed erythropoietin. When incubated at 1% oxygen, astrocytes showed >100-fold time-dependent erythropoietin mRNA accumulation, as measured with the quantitative reverse transcription-polymerase chain reaction. The specificity of hypoxic gene induction in these cells was confirmed by quantitative Northern blot analysis showing hypoxic up-regulation of mRNA encoding the vascular endothelial growth factor, but not of other genes. These findings demonstrate that erythropoietin and its receptor are expressed in the brain of primates as they are in rodents, and that, at least in mice, primary astrocytes are a source of cerebral erythropoietin expression which can be up-regulated by reduced oxygenation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9081618     DOI: 10.1111/j.1460-9568.1996.tb01252.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  120 in total

1.  Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.

Authors:  F T Ruschitzka; R H Wenger; T Stallmach; T Quaschning; C de Wit; K Wagner; R Labugger; M Kelm; G Noll; T Rülicke; S Shaw; R L Lindberg; B Rodenwaldt; H Lutz; C Bauer; T F Lüscher; M Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway.

Authors:  Myoung-Gwi Ryou; Ran Liu; Ming Ren; Jie Sun; Robert T Mallet; Shao-Hua Yang
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

3.  Erythropoietin: still on the neuroprotection road.

Authors:  Nelvys Subirós; Diana García Del Barco; Rosa M Coro-Antich
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

4.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 5.  Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models.

Authors:  Johannes Vogel; Max Gassmann
Journal:  J Physiol       Date:  2011-01-31       Impact factor: 5.182

6.  The Differential Effects of Erythropoietin Exposure to Oxidative Stress on Microglia and Astrocytes in vitro.

Authors:  Praneeti Pathipati; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2017-05-17       Impact factor: 2.984

7.  Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Ellen M Christensen; Jens D Bukh; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Neuropsychopharmacology       Date:  2013-12-10       Impact factor: 7.853

8.  Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats.

Authors:  R J Macias-Velez; L Fukushima-Díaz de León; C Beas-Zárate; M C Rivera-Cervantes
Journal:  J Mol Neurosci       Date:  2019-05-03       Impact factor: 3.444

9.  Erythropoietin negatively regulates pituitary ACTH secretion.

Authors:  Soumyadeep Dey; Tyler Scullen; Constance Tom Noguchi
Journal:  Brain Res       Date:  2015-03-09       Impact factor: 3.252

Review 10.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.